Imunis is a Health Care startup with a focus on improving immune health for patients, medical providers, and society. The company, founded in 2019 and headquartered in Hong Kong S.a.r., aims to revolutionize the way immune health data is recorded, tracked, and shared. Recognizing the significant value of vaccines in preventative health, Imunis has developed a platform to optimize immune health by providing the right vaccines at the right time, adapting to evolving disease landscapes and healthcare insights.
Imunis offers a range of solutions to facilitate its mission. The Imunis App acts as an interoperable vaccine wallet, allowing patients to document their vaccine history and stay informed about their immune health status in real-time, aligning with changing recommendations. Meanwhile, the Imunis Clinic Portal connects seamlessly with medical records systems, offering digital patient status updates to healthcare providers. This not only saves valuable consultation time but also enhances the quality of patient care. Furthermore, the Imunis Schools Portal supports families by enabling them to share accurate vaccine data with educational institutions, thus minimizing the risks of infectious disease outbreaks in a convenient and cost-effective manner.
Additionally, Imunis provides Digital Schedules and Content that furnish the latest global vaccine recommendations in digital format and local languages. This is essential for digital health providers to access current content and power their healthcare solutions using APIs. As of now, there is no public information available regarding Imunis' latest investment and the involved investors. However, the company's dedication to advancing immune health through innovative digital solutions positions it at the forefront of the healthcare industry.
There is no investment information